Levosimendan

• Target :

  Potassium Channel|||Carbonic Anhydrase|||Autophagy|||PDE

• Related Pathways :

  Metabolism|||Membrane transporter/Ion channel|||Autophagy

• Purity :

  0.9991

• Bioactivity :

  Levosimendan (OR1259) is a calcium sensitizer used in the management of acutely decompensated congestive heart failure. It increases the sensitivity of the heart to calcium, thus increasing cardiac contractility without a rise in intracellular calcium. Levosimendan exerts its effect by increasing calcium sensitivity of myocytes by binding to cardiac troponin C in a calcium-dependent manner.

• Smiles :

  C[C@H]1C(C2=CC=C(NN=C(C#N)C#N)C=C2)=NNC(=O)C1

• Molecular Formula :

  C14H12N6O

• Molecular Weight :

  280.28

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  141505-33-1